View all cases
UPC APP 11272/2025
EP2401365 · REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Respondents
- BioNTech SEOperating co.
- BioNTech Manufacturing GmbHOperating co.
- BioNTech Manufacturing Marburg GmbHOperating co.
- BioNTech Innovative Manufacturing Services GmbHOperating co.
- BioNTech Europe GmbHOperating co.
- Pfizer Manufacturing Belgium NVOperating co.
- Pfizer SASOperating co.
- Pfizer ABOperating co.
- Pfizer Inc.Operating co.
Representatives- Christine Kanz-Hoyng Rokh Monegier
- Tobias J. Hessel-Clifford Chance Partnerschaft mbB
- Division
- Munich LD
- Judges
- Technology
- ChemistryBiotechnology
- Language
- —
- First decided
- Apr 9, 2025
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich LD | Locked |
| Judge András Kupecz | Locked |
At the UPC: Promosome LLC (15 cases)·BioNTech Group (21 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 14 other proceedings
UPC CoA 146/2026·UPC CoA 147/2026·UPC CoA 148/2026·UPC CFI 2819/2026·UPC CFI 2821/2026 and 9 more
Decisions
- 2025-04-09
Summary: The Munich Local Division issued an order on Promosome LLC v. BioNTech/Pfizer infringement proceedings (EP 2 401 365), addressing security for costs applications by both BioNTech/Pfizer groups. The court determined the appropriate amount of security, accepting the claimant's willingness to provide security by deposit. The court fixed the security amount based on the recoverable costs ceiling rather than the defendants' requested EUR 5,000,000.
Show the legal issues (3)
- Security for costs (R. 158 RoP, Art. 69.4 UPCA)
- Amount of security: German RVG vs. UPC cost ceiling
- Security by deposit vs. bank guarantee
Documents
- 6C7EEEDF5801EB90DEB559E1EFC67FE0_en.pdf2025-04-09EN